BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 23789590)

  • 1. Vaginal microbiota and its role in HIV transmission and infection.
    Petrova MI; van den Broek M; Balzarini J; Vanderleyden J; Lebeer S
    FEMS Microbiol Rev; 2013 Sep; 37(5):762-92. PubMed ID: 23789590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the vaginal microbiota with probiotics as a means to counteract infections.
    Reid G; Dols J; Miller W
    Curr Opin Clin Nutr Metab Care; 2009 Nov; 12(6):583-7. PubMed ID: 19741517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner.
    Doerflinger SY; Throop AL; Herbst-Kralovetz MM
    J Infect Dis; 2014 Jun; 209(12):1989-99. PubMed ID: 24403560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of infection and transmission of HIV-1 and lack of significant impact on the vaginal commensal lactobacilli by carbohydrate-binding agents.
    Petrova MI; Mathys L; Lebeer S; Noppen S; Van Damme EJ; Tanaka H; Igarashi Y; Vaneechoutte M; Vanderleyden J; Balzarini J
    J Antimicrob Chemother; 2013 Sep; 68(9):2026-37. PubMed ID: 23640125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between sex hormones, the vaginal microbiome and immunity in HIV-1 susceptibility in women.
    Wessels JM; Felker AM; Dupont HA; Kaushic C
    Dis Model Mech; 2018 Aug; 11(9):. PubMed ID: 30154116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The barrier to HIV transmission provided by genital tract Lactobacillus colonization.
    Mirmonsef P; Spear GT
    Am J Reprod Immunol; 2014 Jun; 71(6):531-6. PubMed ID: 24661438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity of vaginal microbiota in sub-Saharan Africa and its effects on HIV transmission and prevention.
    Bayigga L; Kateete DP; Anderson DJ; Sekikubo M; Nakanjako D
    Am J Obstet Gynecol; 2019 Feb; 220(2):155-166. PubMed ID: 30321529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells.
    Zárate G; Nader-Macias ME
    Lett Appl Microbiol; 2006 Aug; 43(2):174-80. PubMed ID: 16869901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct Immune Responses Elicited From Cervicovaginal Epithelial Cells by Lactic Acid and Short Chain Fatty Acids Associated With Optimal and Non-optimal Vaginal Microbiota.
    Delgado-Diaz DJ; Tyssen D; Hayward JA; Gugasyan R; Hearps AC; Tachedjian G
    Front Cell Infect Microbiol; 2019; 9():446. PubMed ID: 31998660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of sex hormones and the vaginal microbiome in susceptibility and mucosal immunity to HIV-1 in the female genital tract.
    Vitali D; Wessels JM; Kaushic C
    AIDS Res Ther; 2017 Sep; 14(1):39. PubMed ID: 28893284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gynecologic health and disease in relation to the microbiome of the female reproductive tract.
    Green KA; Zarek SM; Catherino WH
    Fertil Steril; 2015 Dec; 104(6):1351-7. PubMed ID: 26597627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urogenital pathogen inhibition and compatibility between vaginal Lactobacillus strains to be considered as probiotic candidates.
    Juárez Tomás MS; Saralegui Duhart CI; De Gregorio PR; Vera Pingitore E; Nader-Macías ME
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):399-406. PubMed ID: 21862199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis.
    Sha BE; Zariffard MR; Wang QJ; Chen HY; Bremer J; Cohen MH; Spear GT
    J Infect Dis; 2005 Jan; 191(1):25-32. PubMed ID: 15592999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defence factors of vaginal lactobacilli.
    Kovachev S
    Crit Rev Microbiol; 2018 Feb; 44(1):31-39. PubMed ID: 28418713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The vaginal microbiota and susceptibility to HIV.
    Buve A; Jespers V; Crucitti T; Fichorova RN
    AIDS; 2014 Oct; 28(16):2333-44. PubMed ID: 25389548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lactobacilli administration in the vaginal tract of mice: evaluation of side effects and local immune response by local administration of selected strains.
    Vintiñi E; Ocaña V; Elena Nader-Macías M
    Methods Mol Biol; 2004; 268():401-10. PubMed ID: 15156050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lower genital tract microbiota in relation to cytokine-, SLPI- and endotoxin levels: application of checkerboard DNA-DNA hybridization (CDH).
    Nikolaitchouk N; Andersch B; Falsen E; Strömbeck L; Mattsby-Baltzer I
    APMIS; 2008 Apr; 116(4):263-77. PubMed ID: 18397461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal microbiota and sexually transmitted infections that may influence transmission of cell-associated HIV.
    Cone RA
    J Infect Dis; 2014 Dec; 210 Suppl 3(Suppl 3):S616-21. PubMed ID: 25414415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genital econiche: focus on microbiota and bacterial vaginosis.
    Danielsson D; Teigen PK; Moi H
    Ann N Y Acad Sci; 2011 Aug; 1230():48-58. PubMed ID: 21824165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Lactobacilli and Lactoferrin in the Mucosal Cervicovaginal Defense.
    Valenti P; Rosa L; Capobianco D; Lepanto MS; Schiavi E; Cutone A; Paesano R; Mastromarino P
    Front Immunol; 2018; 9():376. PubMed ID: 29545798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.